Acquisition News Causes Strong Pre-Market Buying Pressure

Acquisition News Causes Strong Pre-Market Buying Pressure

By: Tomas Ronolski - AllPennyStocks.com News

Wednesday, June 15, 2022

A Michigan-based healthcare company is turning heads Wednesday morning after it was announced that the company has signed a definitive agreement to acquire substantially all of the assets of Revo Squared LLC ("Revo"), according to the release. This caused traders to bid up shares of Zomedica Corp (NYSE American:ZOM) before Wednesday’s opening bell.

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment.

Traders appear to be bullish on the news as shares of this small cap are currently bid up at $0.243/share (+10.91% implied open for sellers) at the time of writing. This could be an interesting stock to watch during Wednesday’s regular session!


Copyright © 2022 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Shares on the Rise Following Partnership News With Major Potato Chip Brand
Re-Classification of Marijuana Sends Shares of Cannabis Operator on a Tear
Biotech Soars on Research Collaboration And License Agreement Release
Most Popular
FREE Newsletter


Back to Top